Watch On-Demand

Cut through the noise.
Create clarity.

Over the past forty years, obesity has grown to a full-scale epidemic. Are new weight loss drugs like Ozempic® and Wegovy® the solution? Everywhere you turn there’s an opinion. Miracle cure. Band-aid solution. Patient Right. Employer Burden. One thing is for certain — there’s a lot of noise.

The Employer Impact Report on Weight Loss Drugs will be delivered through a three-part webinar event designed to help you create clarity and identify a path forward. Experts from health care, pharmacy, employee benefits, employment law and more will simplify everything employers need to know in the brave new world of GLP-1s.

Employer Impact Report: Weight Loss Drugs – Webinar Series

Session 1

Weigh Your Options

Please complete the form above to watch this session on-demand.

  • Explore the history of obesity and weight loss treatment
  • Understand the impact and cultural significance of GLP-1s
  • Determine how to design a sustainable solution for your organization
  • Walk away equipped to address weight loss drug demand

 

Employer Impact Report: Weight Loss Drugs – Webinar Series

Session 2

Explore the Landscape

Please complete the form above to watch this session on-demand.

  • Pharmacist-led clinical evaluation of GLP-1s
  • Examine the weight loss drug landscape and the outlook for cost and access
  • Identify employers’ options to balance financial goals and employee care
  • Shape a strategic response to the impacts of obesity AND weight loss drugs
Employer Impact Report: Weight Loss Drugs – Webinar Series

Session 3

Chart Your Course

Please complete the form above to watch this session on-demand.

  • Understand the dynamic between employee rights and employer obligations
  • Weigh the culture and employee satisfaction impacts of decisions surrounding GLP-1s
  • Consider compliance challenges associate with weight loss drug coverage
  • Examine the impact of weight bias and stigma in the workplace
Employer Impact Report: Weight Loss Drugs – Webinar Series
  • Series
    Moderator

    Jim Harenberg, CPBS
    Principal | Chief Operating Officer

    Read Bio
  • Session 1

    Amber Chittenden
    Principal | Chief Client Officer

    Read Bio

  • Sarah Michaels, RN, CPBS
    VP of Kinetiq Health

    Read Bio
  • Session 2

    Nicole Noel, PharmD, MBA

    Nicole Noel, PharmD, MBA
    Director of Clinical and Account Management | Innovative Rx Strategies

    Read Bio

  • Shravan Patel, PharmD
    Managed Care Pharmacy Resident | Innovative Rx Strategies

    Read Bio
  • Session 3

    Amber Chittenden
    Principal | Chief Client Officer

    Read Bio

  • John Maley
    Partner at Barnes & Thornburg

    Read Bio
  • January 25, 2024

    Employer Impact Report: History of GLP-1s

    Drugs for diabetes and weight loss are a part of the cultural conversation today. But how did we get there. Examine the history of GLP-1s.

  • January 22, 2024

    Apex Announces Employer Impact Report on Weight Loss Drugs

    Apex Benefits is proud to announce a 3-part webinar series on GLP-1s, the Employer Impact Report: Weight Loss Drugs. This series will break down what employers need to know to respond to the growing demand for these expensive medications.

  • June 15, 2020

    How Do You Curb Specialty Drug Spend?

    Drugs can become “specialty drugs” because of the way they are manufactured, distributed, or treat rare disorders, among other reasons. Specialty drugs are expensive, and they can quickly wreck a pharmacy benefit budget, too. Just one specialty drug could cost …